Disclosure Of Fair Value Measurement [Text Block]

GenSight Biologics S.A. - Filing #855040

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of fair value measurement [text block]
3
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
25,941,000 EUR
56,648,000 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
15,279,000 EUR
181,211,000 EUR
1,158,000 EUR
170,024,000 EUR
27,625,000 EUR
15,989,000 EUR
137,726,000 EUR
28,617,000 EUR
181,175,000 EUR
1,158,000 EUR
11,749,000 EUR
1,022,000 EUR
34,015,000 EUR
108,034,000 EUR
152,776,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.